A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Clinical Trial Registration
Related Post
24 October, 2024
Promising new results from RAIDER trial published
24 October 2024: Newly published findings from the TROG
23 October, 2024
New Cancer Australia grant supports TROG work
23 October 2024: TROG Cancer Research is thrilled to
